Not FDA-approved

Hormones & metabolism

MOTS-c

Evidence

Mostly animal studies

Class

Mitochondria-derived peptide

KEY TAKEAWAY

MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA. In mice it improved insulin sensitivity and protected against diet-induced obesity. Human data are early and it is not approved.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

A peptide made by mitochondria that influences metabolism

Studied for

Insulin sensitivity, exercise capacity and healthy aging

Key fact

Improved glucose handling and exercise performance in mice; human data are very early

Route

Injection (research use)

Evidence strength

Mostly animal studies

What it is

What it is

MOTS-c is a mitochondrial-derived peptide. Natural levels rise with exercise and fall with age.

How it works

How it works

In animal studies it activates the AMPK energy-sensing pathway and helps cells use glucose and fat more efficiently.

Regulatory status

Regulatory status

MOTS-c is not approved by the FDA. A related compound has been in early clinical development.

What it is used for

What it is used for

Studied for metabolic disease, obesity and age-related decline. It has no approved medical use.

Side effects and risks

Side effects and risks

Human safety information is limited to small early studies. Long-term effects are unknown.

Citations

Citations

Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21:443-454.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo